Video Experimental Relacionado
Updated: Feb 20, 2026
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
Perspectivas para la implementación del Código Europeo de Práctica contra el Cáncer: Lecciones desde Polonia
Joanna Kufel-Grabowska1, Jacek Jassem1
1Department and Clinic of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.
Health policy (Amsterdam, Netherlands)
|February 18, 2026
Resumen
La implementación del Código Europeo de Práctica contra el Cáncer (CEPC) en Polonia enfrenta barreras como la escasez de personal y el acceso desigual. Abordar estos problemas requiere cambios en la fuerza laboral, organizacionales y culturales para una mayor equidad en la atención oncológica.
Área de la Ciencia:
- Oncología
- Investigación de Servicios de Salud
- Derechos del Paciente
Sus antecedentes:
- El Código Europeo de Práctica contra el Cáncer (CEPC) describe diez derechos del paciente para mejorar la equidad, la calidad y el enfoque centrado en el paciente en la atención oncológica.
- Los datos nacionales de implementación del CEPC, especialmente en Europa Central y Oriental, son escasos.
Objetivo del estudio:
- Evaluar la viabilidad percibida de implementar el Código Europeo de Práctica contra el Cáncer (CEPC) en Polonia.
- Evaluar la preparación nacional para la adopción del CEPC para identificar desafíos y oportunidades de implementación.
Principales métodos:
- Una encuesta en línea transversal de 2024 distribuida a especialistas en oncología y psicooncólogos polacos.
- La viabilidad de cada derecho del CEPC se calificó en una escala Likert de 5 puntos, complementada con análisis temático de comentarios de texto libre.
Principales resultados:
- 225 especialistas proporcionaron calificaciones de viabilidad; 345 enviaron comentarios. Los derechos percibidos como más factibles incluyeron el acceso a la información, la toma de decisiones compartida y las discusiones prioritarias.
- Se identificaron desafíos significativos para lograr un acceso equitativo a la atención óptima, la planificación estructurada de la supervivencia/rehabilitación y la atención por equipos multidisciplinarios.
- Las barreras clave reportadas fueron la escasez de personal, el tiempo de consulta insuficiente, las disparidades en el acceso diagnóstico/terapéutico y las actitudes culturales predominantes.
Conclusiones:
- La implementación exitosa del CEPC en Polonia requiere superar obstáculos laborales, organizacionales y culturales.
- Las prioridades de mejora incluyen el establecimiento de un registro nacional de ensayos clínicos, la mejora de las unidades multidisciplinarias y el fortalecimiento de la rehabilitación, los cuidados paliativos y la formación en comunicación.
- Las acciones propuestas se consideran factibles y potencialmente transferibles a otros sistemas de salud europeos.
Videos de Conceptos Relacionados
01:21Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
02:59Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K